Skip to content

Evaluation of optical imaging in foot ulcer management

Evaluation of optoacoustic imaging and photoplethysmography in patients with foot ulcers: a cross-sectional pilot study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN50978600
Enrollment
40
Registered
2024-07-19
Start date
2024-12-18
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot ulcers Skin and Connective Tissue Diseases

Interventions

Patients with ulcers will be prospectively recruited in the multidisciplinary diabetic foot and vascular clinics. Optoacoustic imaging (OAI) and photoplethysmography (PPG) scans will be performed at s

Sponsors

University of Surrey
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 years or greater 2. Non-healing foot wound for at least 4 weeks despite wound care 3. Scheduled for/referred to routine vascular assessment, multidisciplinary foot team clinic or endovascular revascularisation 4. Willing and able to provide informed consent 5. Vascular ultrasound exam required including Ankle Brachial Pressure Index (ABPI) and Toe Brachial Index (TBI)

Exclusion criteria

Exclusion criteria: 1. Heart failure New York Heart Association (NYHA) =3 2. Systemic inflammation 3. Critically ill, American Society of Anesthesiologists (ASA) IV 4. Extensive foot wounds making OAI scanning impossible 5. No toes to measure TBI 6. Leg wounds or skin conditions preventing ABPI, OAI or ultrasound investigations 7. Participants who are unable to wear the laser safety goggles 8. Tattoos in the field of view for OAI scanner 9. Currently under phototherapy 10. History of photosensitising disease (e.g. porphyria, Lupus erythematosus) 11. Experiencing photo-toxicity associated with currently taking or having taken photosensitizing agents within the previous 72 h (e.g. sulfonamides, ampicillin, tetracycline, doxycycline) 12. Pregnancy

Design outcomes

Primary

MeasureTime frame
1. Tissue oxygenation and blood flow measured using optoacoustic imaging in feet at baseline (all) and after angioplasty (subgroup that receives angioplasty as standard of care) 2. Blood flow measured using photoplethysmography in feet at baseline and after angioplasty (subgroup)

Secondary

MeasureTime frame
1. Ankle brachial pressure index measured using ankle Doppler based estimated ABPI (eABPI) at baseline and after angioplasty (subgroup) 2. Toe brachial pressure index measured using arterial plethysmography with cuff at baseline and after angioplasty (subgroup) 3. Peripheral vascular disease in lower extremity arteries measured with duplex ultrasound at baseline and after angioplasty (subgroup) 4. 1-year outcome (major amputation, death, revascularisation, wound healing) measured using electronic patient records over 1 year

Countries

England, United Kingdom

Contacts

Public ContactChristian Heiss
c.heiss@surrey.ac.uk+44 (0)1483 686693

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026